Stocks & Financial News
Breaking financial news 24/7 courtesy of TradingCharts.com Inc. / TFC Commodity Charts
Fertility Drug and Surgery Market Insights, Growth Outlook, Share Value, Future Trends, Business Overview By 2023
In addition to this, a shift from the traditional cultural viewpoint, the rising age of the average pregnant woman, increased health problems such as infertility and obesity, and a rampant surge in sexually transmitted diseases is pushing the boundaries for great expansion in the global market for fertility treatment. Thus, it is seen that increasing awareness about medical procedures is creating plenty of opportunities for the future of family planning. However, negative externalities such as high cost of treatment and medical complications may challenge the market growth during the forecast period.
According to the research conducted by Market Research Future Reports (MRFR), the global fertility drug and surgery market is expected to witness a CAGR of 9.8% during the forecast period of 2018-2023. Some of the major aspects influencing this growth include health factors such as a spike in global infertility rates, increased gamete donations, obesity, and delayed pregnancies. Some economic factors, such as a rise in disposable incomes and healthcare expenditure around the world, are other crucial factors growing the market. Further, a sedentary lifestyle across the globe is the leading cause of rising infertility, which appears to be boosting the demand for treatment and is driving the market growth.
Request Free Sample Copy of the report “ Fertility Drug and Surgery Market Research Report – Forecast to 2023 ” at: https://www.marketresearchfuture.com/sample_request/7588
The global market for fertility drugs and surgery is dominated by the Americas - owing to increasing infertility, obesity, and delayed pregnancies. From an economic perspective, an increase in the disposable income of an average American household adds to the boost in market growth. This trend is closely followed by Europe, who stood second in 2017 in the global fertility drug and surgery market.
On the other hand, Asia Pacific happens to be the fastest-growing region for this market. It is driven by factors such as increasing awareness amongst people and growing healthcare infrastructure in this region.
Lastly, the Middle East and Africa face issues such as abject poverty and failing economics, making the market lag within this region and causing it to have the least share in this market. However, between the Middle East and Africa, the former seems to hold a bigger portion of the market share owing to increased government funding in healthcare programs and the presence of more developed economies including UAE, Kuwait, and Saudi Arabia
The global fertility drug and surgery market can be segmented on the basis of drug, underlying cause, end-user, procedures, and region.
On the basis of drugs, the global fertility drug and surgery market can be segmented on the basis of clomiphene citrate, letrozole, Serophene, hormone treatment, gonadotrophins.
On the basis of the underlying cause, the global fertility drug and surgery market can be segmented on the basis of male and female
On the basis of end-user, the global fertility drug and surgery market can be segmented on the basis of fertility clinics, hospitals, clinical research institutes, and others.
On the basis of procedures, the global fertility drug and surgery market can be segmented on the basis of hysteroscopy, laparoscopy and robotic laparoscopy, laparotomy/open surgery, egg retrieval, varicocelectomy, vasectomy reversal (vasovasostomy or vasoepididymostomy), sperm retrieval (epididymal aspiration)
On the basis of region, the global fertility drug and surgery market can be segmented on the basis of the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The established players of the global fertility drug and surgery market are Baxter Healthcare Corporation, Eli Lilly, Ferring Pharmaceuticals, Inc., Noven Pharmaceuticalorganon, Inc., Merck & Co. Pharmaceutical Company, Janssen Pharmaceuticals Inc., Pfizer, Inc., Procter & Gamble Pharmaceuticals, Personal Products Company, Emd Serono, Inc., and others.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/fertility-drug-surgery-market-7588
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future
+1 646 845 9312